EFFETTI DELLA SOMMINISTRAZIONE DI UN B2 AGONISTA E DI UN BECHICO IN ASMATICI ED IN PAZIENTI CON OSTRUZIONE CRONICA DELLE VIE AEREE

Translated title of the contribution: Reproterol and fominoben for bronchial asthma and chronic obstructive lung disease

D. Degl'Innocenti, E. Marchi, F. Gigliotti

Research output: Contribution to journalArticle

Abstract

Changes in forced expiratory volume in 1 sec. (FEV1) induced by the administration of a Beta-2 agonist (Reproterol, 500 mcg MDI) and a bechic (Fominoben 40 mg i.v.) were evaluated both in asthmatics and in patients with chronic obstructive lung disease (COLD). In each patient the administration of the drugs was carried out in the following order: Reproterol (R1) → Fominoben (F) → Reproterol (R2). R1, F, R2 induced significant changes in FEV1 when compared to control values (P1. Only in patients with COLD the FEV1 values measured after R2 were significantly greater than those observed after R1 (P

Original languageItalian
Pages (from-to)271-274
Number of pages4
JournalEuropean Review for Medical and Pharmacological Sciences
Volume6
Issue number2
Publication statusPublished - 1984

Fingerprint

reproterol
Chronic Obstructive Pulmonary Disease
Asthma
Forced Expiratory Volume
Cough
Pharmaceutical Preparations
fominoben

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{9666744162184565ba7d19c4dd49533c,
title = "EFFETTI DELLA SOMMINISTRAZIONE DI UN B2 AGONISTA E DI UN BECHICO IN ASMATICI ED IN PAZIENTI CON OSTRUZIONE CRONICA DELLE VIE AEREE",
abstract = "Changes in forced expiratory volume in 1 sec. (FEV1) induced by the administration of a Beta-2 agonist (Reproterol, 500 mcg MDI) and a bechic (Fominoben 40 mg i.v.) were evaluated both in asthmatics and in patients with chronic obstructive lung disease (COLD). In each patient the administration of the drugs was carried out in the following order: Reproterol (R1) → Fominoben (F) → Reproterol (R2). R1, F, R2 induced significant changes in FEV1 when compared to control values (P1. Only in patients with COLD the FEV1 values measured after R2 were significantly greater than those observed after R1 (P",
author = "D. Degl'Innocenti and E. Marchi and F. Gigliotti",
year = "1984",
language = "Italian",
volume = "6",
pages = "271--274",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "2",

}

TY - JOUR

T1 - EFFETTI DELLA SOMMINISTRAZIONE DI UN B2 AGONISTA E DI UN BECHICO IN ASMATICI ED IN PAZIENTI CON OSTRUZIONE CRONICA DELLE VIE AEREE

AU - Degl'Innocenti, D.

AU - Marchi, E.

AU - Gigliotti, F.

PY - 1984

Y1 - 1984

N2 - Changes in forced expiratory volume in 1 sec. (FEV1) induced by the administration of a Beta-2 agonist (Reproterol, 500 mcg MDI) and a bechic (Fominoben 40 mg i.v.) were evaluated both in asthmatics and in patients with chronic obstructive lung disease (COLD). In each patient the administration of the drugs was carried out in the following order: Reproterol (R1) → Fominoben (F) → Reproterol (R2). R1, F, R2 induced significant changes in FEV1 when compared to control values (P1. Only in patients with COLD the FEV1 values measured after R2 were significantly greater than those observed after R1 (P

AB - Changes in forced expiratory volume in 1 sec. (FEV1) induced by the administration of a Beta-2 agonist (Reproterol, 500 mcg MDI) and a bechic (Fominoben 40 mg i.v.) were evaluated both in asthmatics and in patients with chronic obstructive lung disease (COLD). In each patient the administration of the drugs was carried out in the following order: Reproterol (R1) → Fominoben (F) → Reproterol (R2). R1, F, R2 induced significant changes in FEV1 when compared to control values (P1. Only in patients with COLD the FEV1 values measured after R2 were significantly greater than those observed after R1 (P

UR - http://www.scopus.com/inward/record.url?scp=0021710915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021710915&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0021710915

VL - 6

SP - 271

EP - 274

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 2

ER -